144 related articles for article (PubMed ID: 3274356)
1. Enhancement of renal allografts by simultaneous cyclosporine and donor-specific blood transfusion.
Francis DM; Masendycz PJ; Dumble LJ; Clunie GJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1464-6. PubMed ID: 3274356
[No Abstract] [Full Text] [Related]
2. Cyclosporine inhibits nonspecific transfusion-induced immunity in dogs.
Kyriakides GK; Esquenazi V; Olson L; Milgrom M; Miller J
Transplant Proc; 1987 Feb; 19(1 Pt 2):1432-3. PubMed ID: 2978877
[No Abstract] [Full Text] [Related]
3. Three year experience of donor specific transfusion and concomitant cyclosporine A.
Hillis AN; Duguid J; Evans CM; Bone JM; Sells RA
Transplant Proc; 1987 Feb; 19(1 Pt 3):2248-9. PubMed ID: 2978890
[No Abstract] [Full Text] [Related]
4. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation.
Bordes-Aznar J; Odor A; Dib-Kuri A; Gabilondo F; Kasep J; Peña JC; Herrera-Acosta J; Chávez-Peón F
Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080
[No Abstract] [Full Text] [Related]
5. Abrogation of cyclosporine/transfusion-induced enhancement of rabbit skin allografts by increased cyclosporine dosage.
Smit WJ; Masendycz PJ; Dumble LJ; Francis DM; Clunie GJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1427-8. PubMed ID: 3274347
[No Abstract] [Full Text] [Related]
6. The effects of donor specific transfusion and cyclosporine A on graft outcome.
Haberal M; Oner Z; Aybasti N; Arslan G; Turan M; Bilgin N
Transplant Proc; 1987 Feb; 19(1 Pt 3):2269-70. PubMed ID: 3274506
[No Abstract] [Full Text] [Related]
7. Pretransplant transfusion and cyclosporine-induced enhancement of rabbit skin allografts: donor-specific versus third-party blood.
Dieperink H
Transplantation; 1985 Jun; 39(6):688. PubMed ID: 3890300
[No Abstract] [Full Text] [Related]
8. Induction of long-term rat renal allograft survival: a specific synergistic effect of limited pretransplant cyclosporine combined with multiple nonspecific blood transfusions.
Martin DC; Hewitt CW; Black KS; Reyes M; Go C
Transplant Proc; 1987 Feb; 19(1 Pt 1):462-3. PubMed ID: 3274807
[No Abstract] [Full Text] [Related]
9. Effect of cyclosporine A treatment on induction of donor specific unresponsiveness in mongrel dogs following a short course of ALS and donor bone marrow infusion on canine renal allograft function.
Hartner WC; Shaffer D; Markees TG; De Fazio SR; Monaco AP; Gozzo JJ
Transplant Proc; 1991 Feb; 23(1 Pt 1):477-9. PubMed ID: 1990590
[No Abstract] [Full Text] [Related]
10. Prolongation of related rabbit skin allografts by preoperative treatment with donor-specific or third-party transfusion and cyclosporine.
Dumble LJ; Masendycz P; Mottram PL; Francis DM; Clunie GJ
Transplant Proc; 1986 Apr; 18(2):355-6. PubMed ID: 3515672
[No Abstract] [Full Text] [Related]
11. Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation.
Alexander JW; Davies CB; First MR; Cofer BR; Munda R; Madden RL; Hariharan S; Schroeder TJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):485-7. PubMed ID: 8438389
[No Abstract] [Full Text] [Related]
12. Delayed elimination of donor red blood cells is associated with host major histocompatibility complex and donor-specific blood transfusion enhancement of rat renal allograft survival.
Wasowska B; Baldwin WM; Sanfilippo F
Transplant Proc; 1993 Feb; 25(1 Pt 1):241-2. PubMed ID: 8438285
[No Abstract] [Full Text] [Related]
13. Release of interleukins during tolerance and rejection of human renal allografts.
Charpentier B; Lantz O; Lang P; Martin B; Fries D
Transplant Proc; 1987 Feb; 19(1 Pt 2):1572-3. PubMed ID: 3274385
[No Abstract] [Full Text] [Related]
14. Donor-specific blood transfusion reduces cyclosporine effect on the survival of canine renal allografts.
Dienst SG; Amprim FL; Schervish E
Transplant Proc; 1988 Jun; 20(3 Suppl 3):1102-4. PubMed ID: 3291219
[No Abstract] [Full Text] [Related]
15. Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506.
Fabrega AJ; Blanchard JM; Rivas PA; Pollak R
Transplantation; 1993 Dec; 56(6):1579-80. PubMed ID: 7506458
[No Abstract] [Full Text] [Related]
16. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
Kerman RH; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
[TBL] [Abstract][Full Text] [Related]
17. Long-term residual cyclosporine levels following short-term administration in various allograft models demonstrating extensive survival prolongation.
Hewitt CW; Black KS; Gonzalez GA; Dowdy SF; Reyes M; Martin DC; Achauer BM
Transplant Proc; 1987 Feb; 19(1 Pt 2):1244-5. PubMed ID: 3274310
[No Abstract] [Full Text] [Related]
18. Immunosuppressive factors in patients after donor-specific transfusion with administration of cyclosporine.
Yuzawa K; Otsuka M; Yu Y; Sharma N; Iwasaki H; Fukao K; Iwasaki Y
Transplant Proc; 1991 Feb; 23(1 Pt 2):1036-8. PubMed ID: 1824884
[No Abstract] [Full Text] [Related]
19. Induction of Ia in rat pancreas allografts: the effect of donor specific blood transfusion pretreatment or cyclosporin A.
Thomson NM; Perks AG; Jablonski P; Howden B; Maguire J; Scott DF; Marshall VC
Transplant Proc; 1989 Feb; 21(1 Pt 1):507-9. PubMed ID: 2468221
[No Abstract] [Full Text] [Related]
20. Efficacy of cyclosporine in renal transplantation from HLA haploidentical living donors: no benefit of transfusion or additional azathioprine.
Albrechtsen D; Flatmark A; Leivestad T; Brynger H; Frødin L; Groth CG; Lundgren G; Persson N
Transplant Proc; 1990 Feb; 22(1):214-5. PubMed ID: 2408207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
